Detalhe da pesquisa
1.
The Immune Response to Mycobacterium tuberculosis in HIV-1-Coinfected Persons.
Annu Rev Immunol
; 36: 603-638, 2018 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29490165
2.
Unlocking translational machinery for antitubercular drug development.
Trends Biochem Sci
; 49(3): 195-198, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38195289
3.
A tale of two inhibitors: diarylquinolines and squaramides.
EMBO J
; 42(15): e114912, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37435707
4.
A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infection.
PLoS Biol
; 22(4): e3002259, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683873
5.
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies.
Semin Immunol
; 65: 101672, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36469987
6.
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
N Engl J Med
; 388(10): 873-887, 2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808186
7.
Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.
N Engl J Med
; 389(15): 1357-1367, 2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37819954
8.
Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review.
PLoS Pathog
; 20(4): e1011574, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598556
9.
Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye.
Trends Immunol
; 44(9): 712-723, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37543504
10.
Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism.
Cell
; 145(1): 39-53, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21376383
11.
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
N Engl J Med
; 387(9): 810-823, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053506
12.
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
N Engl J Med
; 387(25): 2331-2343, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546625
13.
A novel class of antimicrobial drugs selectively targets a Mycobacterium tuberculosis PE-PGRS protein.
PLoS Biol
; 20(5): e3001648, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639773
14.
Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments.
Clin Microbiol Rev
; 36(4): e0008823, 2023 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38032192
15.
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.
Clin Infect Dis
; 78(1): 144-148, 2024 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606512
16.
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
Clin Infect Dis
; 78(3): 514-517, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879092
17.
Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for Multidrug- and Rifampicin-Resistant Tuberculosis.
Clin Infect Dis
; 78(4): 1043-1052, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37962987
18.
The Impact of Preventive Treatment for Multidrug- and Rifampin-Resistant Tuberculosis Exceeds Trial-Based Estimates.
Clin Infect Dis
; 78(1): 133-143, 2024 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37724763
19.
Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
Clin Infect Dis
; 78(2): 269-276, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874928
20.
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up.
Clin Infect Dis
; 78(1): 164-171, 2024 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773767